EUVIMEDSkopri EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report

East Asian Archives of Psychiatry · 2018

DOI: 10.12809/eaap181706 ↗

At a glance

Fallbericht in East Asian Archives of Psychiatry, 2018. Cited 1 times so far (Crossref). The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Clozapine is considered to be more effective than other antipsychotic drugs for treating treatmentresistant schizophrenia. However, side effects of clozapine include agranulocytosis and, less commonly, cardiovascular disease, which is occasionally fatal. We describe a 56-year-old woman who developed clozapine-related paroxysmal supraventricular tachycardia during clozapine dose titration and had a recurrence despite being treated with verapamil. For treatment-resistant schizophrenia, a slow titration of the clozapine dose is necessary, and potential cardiac side-effects should be monitored.

Cite

APA

(2018). Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report. East Asian Archives of Psychiatry. https://doi.org/10.12809/eaap181706

Vancouver

Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report. East Asian Archives of Psychiatry. 2018. doi:10.12809/eaap181706

BibTeX
@article{euvimed2018,
  title = {Clozapine-related Paroxysmal Supraventricular Tachycardia: a Case Report},
  journal = {East Asian Archives of Psychiatry},
  year = {2018},
  doi = {10.12809/eaap181706}
}
Start for free →